ARCHIVES

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

This article is from The Cancer Letter archive.

Vol. 23 No. 7 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

News Analysis: Industry’s Accelerated Recovery Initiative May Push Manufacturers Toward Collusion

October 5, 2012

Rhoads Presses For Greater Emphasis On Etiology In DNCP; Workshops Develop New Research Leads

July 16, 1976

RFAs Available.

July 4, 2003

Cancer Mortality Rate Down 1.3 Percent, ACS Report Finds

July 30, 2010

Dana-Farber Picks Rosenthal To Direct New Center For Integrated Therapies.

June 23, 2000

Agencies Plan Better Reporting Of Adverse Events In Trials.

February 4, 2000